- Trials with a EudraCT protocol (52)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (94)
52 result(s) found for: Trimethoprim.
Displaying page 1 of 3.
EudraCT Number: 2006-001313-15 | Sponsor Protocol Number: 555555 | Start Date*: 2006-06-20 |
Sponsor Name:University of Dundee | ||
Full Title: Cranberry product versus low dose trimethoprim in the prevention of recurrent urinary infections in older women: a double blind randomised trial of effectiveness and acceptability | ||
Medical condition: Recurrent urinary tract infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003403-29 | Sponsor Protocol Number: TMP-SMT-CVVH | Start Date*: 2014-09-26 |
Sponsor Name:Innsbruck Medical University | ||
Full Title: Pharmacokinetics of trimethoprim-sulfametrole in critically ill patients on continuous veno-venous haemofiltration | ||
Medical condition: Life-threatening infection treated with trimethoprim-sulfametrole (Rokiprim) in critically ill patients on and off continuous veno-venous haemfiltration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000864-28 | Sponsor Protocol Number: DAP-PEDOST-11-03 | Start Date*: 2014-01-02 | |||||||||||||||||||||
Sponsor Name:Cubist Pharmaceuticals, LLC | |||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects With Acute Hematogeno... | |||||||||||||||||||||||
Medical condition: Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) HU (Completed) IT (Completed) ES (Completed) GR (Completed) LV (Completed) GB (Completed) EE (Completed) BG (Completed) FR (Completed) SI (Completed) Outside EU/EEA | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022762-27 | Sponsor Protocol Number: PEN1011 | Start Date*: 2010-11-09 | |||||||||||
Sponsor Name:Klinisk Farmakologisk Afdeling, Bispebjerg | |||||||||||||
Full Title: Studiets formål er, at undersøge hvorvidt v-penicillin og trimethoprim inducerer oxidativt stress i raske frivillige forsøgsdeltagere. En eventuel induktion vurderes ud fra målinger på 8-oxoGuo- og... | |||||||||||||
Medical condition: Oxidative stress induced by antibiotics | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005627-21 | Sponsor Protocol Number: APHP211043 | Start Date*: 2022-08-31 |
Sponsor Name:APHP | ||
Full Title: 3-day intravenous antibiotic treatment versus 3-day intravenous followed by 7-day oral antibiotic treatment for acute pyelonephritis in children 1 month to 3 years old: a non-inferiority open rando... | ||
Medical condition: Acute pyelonephritis in children 1 month to 3 years old | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004297-14 | Sponsor Protocol Number: SLH2015001 | Start Date*: 2016-06-08 |
Sponsor Name:Streeklaboratorium voor de volksgezondheid Kennemerland | ||
Full Title: Effectiveness of fosfomycin versus nitrofurantoin in Dutch risk groups with cystitis: a pilot study (Uri-weg study) | ||
Medical condition: Cystitis without tissue invasion (uncomplicated cytitis) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000219-25 | Sponsor Protocol Number: MRSA | Start Date*: 2013-07-18 |
Sponsor Name:AOU Meyer | ||
Full Title: Early eradication of S. Aureus (MRSA) in patients with cystic fibrosis: a randomized multicenter study. | ||
Medical condition: Patients affected by cystic fibrosis and who present an initial infection of MRSA. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004424-38 | Sponsor Protocol Number: SUTRICA | Start Date*: 2013-01-29 | ||||||||||||||||
Sponsor Name:Department of Haematology, Aalborg University Hospital | ||||||||||||||||||
Full Title: A randomized, open-label phase III study of Clarithromycin, Sulfamethoxa-zole/Trimethoprim or observation in combination with standard therapy in patients with newly diagnosed multiple myeloma | ||||||||||||||||||
Medical condition: Multiple myeloma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003444-80 | Sponsor Protocol Number: 2020-01471 | Start Date*: 2020-11-17 |
Sponsor Name:Sahlgrenska University Hospital | ||
Full Title: Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in addition to Minimum Inhibitory Concentration (MIC) to gu... | ||
Medical condition: Periprosthetic hip or knee joint infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003282-17 | Sponsor Protocol Number: 190801 | Start Date*: 2020-02-11 | |||||||||||
Sponsor Name:Thomas Benfield | |||||||||||||
Full Title: Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study | |||||||||||||
Medical condition: Gram-negative bacteremia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005409-38 | Sponsor Protocol Number: TriSulfa-FPI-1 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI) | |||||||||||||
Full Title: Pilot study phase III to evaluate the efficacy and safety of Trimethoprim-sulfamethoxazole in the treatment of idiopathic pulmonary fibrosis | |||||||||||||
Medical condition: Ambulatory patients, men and women, with well-established diagnosis of idiopathic pulmonary fibrosis. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001468-13 | Sponsor Protocol Number: 2020PI028 | Start Date*: 2021-07-12 | |||||||||||
Sponsor Name:Centre Hospitalier Régional Universitaire de Nancy | |||||||||||||
Full Title: Short bowel syndrome and study of the absorption of antibiotics with good oral bioavailability | |||||||||||||
Medical condition: Patient with short bowel syndrome treated with antibiotics for urinary parenchymal infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022518-16 | Sponsor Protocol Number: KADFUT | Start Date*: 2011-07-13 | ||||||||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: A prospective single blind randomised controlled study to compare the outcomes of patients with diabetes and clinically non-infected ischaemic and neuropathic foot ulcers treated with and without ... | ||||||||||||||||||
Medical condition: foot ulcers with no clinical signs of infection in patients with diabetes. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-000309-21 | Sponsor Protocol Number: PREDICT_Trial_Amd_04 | Start Date*: 2013-10-01 | |||||||||||
Sponsor Name:Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | |||||||||||||
Full Title: Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary Tract | |||||||||||||
Medical condition: Infants with vesicoureteral reflux grade III-V, started before the first symptomatic infection. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) LT (Completed) ES (Ongoing) DE (Ongoing) SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000577-77 | Sponsor Protocol Number: Uni-Koeln-1400 | Start Date*: 2013-07-11 | ||||||||||||||||
Sponsor Name:University of Düsseldorf | ||||||||||||||||||
Full Title: EARLY ORAL SWITCH THERAPY IN LOW-RISK STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTION ACRONYM: SABATO (Staphylococcus aureus Bacteremia Antibiotic Treatment Options) | ||||||||||||||||||
Medical condition: Low risk Staphylococcus aureus bloodstream infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-000338-20 | Sponsor Protocol Number: MK-7655A-021 | Start Date*: 2019-06-26 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Tha... | |||||||||||||
Medical condition: Treatment of bacterial infections in pediatric populations | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) PL (Completed) Outside EU/EEA ES (Completed) BG (Completed) GR (Completed) NO (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003487-36 | Sponsor Protocol Number: 1 | Start Date*: 2015-12-23 | |||||||||||
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Alternatives to prophylactic antibiotics for the treatment of recurrent urinary tract infection in women | |||||||||||||
Medical condition: Recurrent urinary tract infection in women | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022886-92 | Sponsor Protocol Number: MWJ20100512V2 | Start Date*: 2011-04-19 |
Sponsor Name:Nottingham University Hospital NHS Trust | ||
Full Title: The effect of probiotics on the incidence of spontaneous bacterial peritonitis in patients with cirrhosis and ascites. | ||
Medical condition: cirrhosis and hepatic failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-004927-12 | Sponsor Protocol Number: 06-09-2006-0208-296-2401 | Start Date*: 2009-11-20 |
Sponsor Name:St Helier Hospital NHS Trust | ||
Full Title: A double-blind randomised placebo controlled study of cotrimoxazole in the treatment of advanced pulmonary fibrosis | ||
Medical condition: Advanced pulmonary fibrosis including common subtypes of usual interstitial pneumonitis and fibrotic non specific pneumonitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2013-005475-41 | Sponsor Protocol Number: MLX | Start Date*: 2014-11-05 |
Sponsor Name:UZ Brussel | ||
Full Title: Sulfamethoxazole treatment of primary PREPL deficiency | ||
Medical condition: Hypotonia-cystinuria syndrome and isolated PREPL deficiency. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
